ReAlta Life Sciences
Pre-clinicalDevelops complement-targeted therapeutics for inflammatory and rare diseases.
Founded
2018
Focus
RNA & Gene TherapyViral Technology
About
Develops complement-targeted therapeutics for inflammatory and rare diseases.
Funding History
2Total raised: $67M
Series B$47MNew Enterprise AssociatesJan 15, 2022
Series A$20MNew Enterprise AssociatesJun 15, 2020
Company Info
TypePrivate
Founded2018
LocationNorfolk, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile